# Thrombectomy In TANdem Occlusion

Study · id `cardio:ct-nct03978988` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT03978988](<https://clinicaltrials.gov/study/NCT03978988>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT03978988

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is active, not recruiting. It enrolled 432 participants.

## Technical summary

Registry record NCT03978988. Randomized; no masking; primary purpose other. Start 2020-04-29 (actual); primary completion 2025-03-08 (actual). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose other
- Phase: Not applicable
- Enrolled: 432 participants (enrolled count; ClinicalTrials.gov record NCT03978988, source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)
- Started: 2020-04-29 (actual) (ClinicalTrials.gov record NCT03978988, source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)
- Primary completion: 2025-03-08 (actual) (ClinicalTrials.gov record NCT03978988, source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)
- Completion: 2026-03-06 (anticipated) (ClinicalTrials.gov record NCT03978988, source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)
- Countries: France (ClinicalTrials.gov record NCT03978988, source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "ACTIVE\_NOT\_RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct03978988-2025-06-05`, retrieved 2026-10-26)

## The registry's words

- Brief title: Thrombectomy In TANdem Occlusion
- Acronym: TITAN
- Condition: Carotid Artery Diseases
- Condition: Thrombectomy
- Condition: Tandem Occlusion
- Condition: Stroke
- Intervention (Device): Carotid Stenting
- Intervention (Drug): Procedural Aspirin
- Intervention (Drug): Dual dual antiplatelet therapy after 24-hours imaging follow-up
- Intervention (Procedure): Intracranial thrombectomy
- Lead sponsor: Central Hospital, Nancy, France
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Central Hospital, Nancy, France (`cardio:org-central-hospital-nancy-france`)

## Provenance

Content hash: 6358dfffc7ff91e4a56a5ea24cb1039cbc84c32c2e92e35480f644ba98bf2d8a
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
